Related Experiment Video
Updated: Jun 29, 2026

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
Versatile and comprehensive hyperspectral imaging tool for molecular neuronavigation: a case study on cerebral
Dorotea Nardini1,2, Anam Toaha1,2, Camilla Bonaudo3
1University of Florence, Department of Physics and Astronomy, Sesto Fiorentino, Italy.
A new hyperspectral imaging system, HyperProbe1.1, offers real-time, label-free molecular and metabolic data for brain tumor characterization. This technology aids in surgical guidance and early tissue assessment, overcoming limitations of current methods.
Area of Science:
- Biomedical Optics
- Neurosurgical Oncology
- Molecular Imaging
Background:
- Accurate brain tumor characterization is crucial for neurosurgery but faces challenges with current imaging and histopathology methods.
- Preoperative imaging can be unreliable during surgery due to brain shift, and histopathology delays treatment decisions.
- There is a need for real-time, label-free tools for intraoperative guidance and early tissue assessment.
Purpose of the Study:
- To develop and validate a hyperspectral imaging system, HyperProbe1.1 (HP1.1), for comprehensive, label-free molecular and metabolic characterization of brain tissue.
- To enable real-time, spatially resolved biomolecular information for improved surgical guidance and tissue assessment.
Main Methods:
- HP1.1 captures reflectance and ultraviolet-excited autofluorescence images across narrow spectral bands.
- The system maps hemoglobin, cytochrome c oxidase, oxygen saturation, and metabolic cofactors like nicotinamide adenine dinucleotide and flavin adenine dinucleotide.
- Validation was performed using standardized phantoms and ex vivo glioma samples.
Main Results:
- HP1.1 successfully detected spectral features in phantoms and distinguished glioma tissues by histological grade.
- The system generated rapid, spatially resolved molecular contrast maps.
- Demonstrated strong performance in label-free tissue assessment.
Conclusions:
- HP1.1 provides high-content, rapid, label-free biomolecular imaging.
- This system is a powerful platform for noninvasive tissue assessment in experimental settings.
- HP1.1 shows promise for future intraoperative neurosurgical applications.
More Related Videos
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
08:02A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents
Published on: July 16, 2020